Terug
Dagbereik
€ 3,85
€ 16,45
52-Weeksbereik
€ 3,85
€ 16,45
Volume
1.000
50D / 200D Gem.
€ 16,45
/
€ 15,24
Vorige Slotkoers
€ 16,45
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,3 | 0,3 |
| P/B | 0,1 | 3,0 |
| ROE % | -50,0 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 51,77
-€ 210,69 – € 7,52
|
8,79B | 1 |
| FY2029 |
€ 150,14
-€ 21,81 – € 611,00
|
42,49B | 1 |
| FY2028 |
€ 59,17
-€ 8,60 – € 240,80
|
22,53B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-17 | -€ 20,69 | -€ 0,10 | +99,5% |
| 2025-12-15 | -€ 0,10 | -€ 0,06 | +35,2% |
| 2025-09-15 | N/A | -€ 0,04 | — |
| 2025-06-11 | N/A | -€ 0,15 | — |
| 2025-03-17 | N/A | -€ 0,07 | — |
| 2024-12-16 | -€ 0,12 | -€ 0,08 | +33,3% |
| 2024-09-17 | -€ 0,12 | -€ 0,12 | +5,6% |
| 2024-06-13 | -€ 0,12 | -€ 0,01 | +88,2% |
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -3,84B
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-50,01%
ROIC-19,17%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,09
Current Ratio28,99
Interest Coverage-46,81
Waardering
P/E Ratio
-0,33
Forward P/EN/A
P/B Ratio0,09
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -3,84B |
| ROE | -50,01% | ROA | -24,60% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3,84B |
| ROIC | -19,17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 28,99 |
| Interest Coverage | -46,81 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,33 | Forward P/E | N/A |
| P/B Ratio | 0,09 | P/S Ratio | N/A |
| PEG Ratio | -1,88 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -299,00% | ||
| Market Cap | 1,28B | Enterprise Value | -12,56B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -3,84B | -2,88B | -2,64B | -5,56B | -4,68B |
| EPS (Diluted) | -52,63 | -41,85 | -40,48 | -95,99 | -90,33 |
| Gross Profit | -8,05M | 0,0 | -14,50M | -24,62M | -132,47M |
| Operating Income | -3,79B | -3,52B | -4,54B | -7,90B | -6,62B |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 15,62B | 3,45B | 5,05B | 7,05B | 5,51B |
| Total Liabilities | 2,02B | 1,68B | 2,25B | 2,62B | 3,48B |
| Shareholders' Equity | 13,60B | 1,76B | 2,79B | 4,43B | 2,04B |
| Total Debt | 1,24B | 397,00M | 665,00M | 933,00M | 2,53B |
| Cash & Equivalents | 15,08B | 2,92B | 4,45B | 6,73B | 4,56B |
| Current Assets | 15,49B | 3,34B | 4,94B | 6,97B | 5,35B |
| Current Liabilities | 534,23M | 732,08M | 905,64M | 1,09B | 1,46B |